IBD leads to important economic losses and higher antibotic consumption
10% reduction in profit is estimated in subclinical IBD cases
FEATURED
NEWSLETTER
DON’T MISS ANY UPDATES ON GUMBORO PROTECTION
VIDEOS
FEATURED
DON’T MISS ANY UPDATES ON GUMBORO PROTECTION
VIDEOS
WEBINARS
Don´t miss our webinars on Infectious Bursal disease
Don't miss any updates
Controller: LABORATORIOS HIPRA, S.A.
Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.
For further information, please check our detailed information on Data Protection.